Alimta and disease progression Patient Reports February 12, 2012

Alimta Side Effects Report #4891965-2
Alimta side effect was reported by a Physician from ITALY on Jan 10, 2006. Male patient, 52 years of age, was diagnosed with pleural mesothelioma malignant advanced and was treated with Alimta. After drug was administered, patient experienced the following side effects: cardiac arrest , cardiovascular disorder, disease progression, intestinal obstruction, mucosal inflammation. Alimta dosage: unknown. During the same period patient was treated with FOLIC ACID, VITAMIN B12, DILTIAZEM HYDROCHLORIDE, LUVION, FUROSEMIDE, UNIPRIL. Patient was hospitalized. Patient died on 12/04/2005.

Alimta Side Effects Report #4928175-6
Alimta side effect was reported by a Physician from FRANCE on Feb 08, 2006. Male patient, 76 years of age, weighting 145.5 lb, was diagnosed with pleural mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, disease progression, mucosal inflammation, pyrexia. Alimta dosage: 900 MG, OTHER INTRAVENOUS. During the same period patient was treated with CISPLATIN, FOLIC ACID, VITAMIN B12. Patient recovered.

Alimta Side Effects Report #4916954-0
Alimta side effect was reported by a Physician from AUSTRALIA on Jan 30, 2006. Female patient, 75 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: confusional state, disease progression, loss of consciousness, pleural mesothelioma malignant. Alimta dosage: unknown. During the same period patient was treated with VITAMIN B12, FOLIC ACID, CARBOPLATIN. Patient was hospitalized. Patient died on 01/01/2005.

Alimta Side Effects Report #4901157-6
Alimta side effect was reported by a Health Professional from UNITED STATES on Jan 11, 2006. Male patient, 73 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: disease progression, malignant neoplasm progression, nausea . Alimta dosage: 700 MG, OTHER, INTRAVENOUS. During the same period patient was treated with CISPLATIN, VITAMIN B12. Patient was hospitalized. Patient died on 10/05/2005.


Alimta Side Effects Report #5743874-4
Alimta side effect was reported by a Physician from JAPAN on May 10, 2008. Male patient, weighting 163.1 lb, was diagnosed with pleural mesothelioma malignant, prophylaxis, cancer pain and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia macrocytic, disease progression, performance status decreased, renal impairment. Alimta dosage: 750 MG, OTHER. During the same period patient was treated with RANDA, FOLIAMIN, PANVITAN, CYANOCOBALAMIN, DECADRON. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #5774864-3
Alimta side effect was reported by a Physician from JAPAN on June 04, 2008. Male patient, weighting 163.1 lb, was diagnosed with pleural mesothelioma malignant, prophylaxis, cancer pain and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia macrocytic, disease progression, performance status decreased, renal impairment. Alimta dosage: 750 MG, OTHER. During the same period patient was treated with RANDA, FOLIAMIN, PANVITAN, CYANOCOBALAMIN, DECADRON. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #5891692-9
Alimta side effect was reported by a Physician from JAPAN on June 04, 2008. Male patient, weighting 163.1 lb, was diagnosed with pleural mesothelioma malignant, prophylaxis, cancer pain and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia macrocytic, disease progression, performance status decreased, renal impairment. Alimta dosage: 750 MG, OTHER. During the same period patient was treated with RANDA, FOLIAMIN, PANVITAN, CYANOCOBALAMIN, DECADRON. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #6045806-0
Alimta side effect was reported by a Physician from JAPAN on June 04, 2008. Male patient, weighting 163.1 lb, was diagnosed with pleural mesothelioma malignant, prophylaxis, cancer pain and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia macrocytic, disease progression, performance status decreased, renal impairment. Alimta dosage: 750 MG, OTHER. During the same period patient was treated with RANDA, FOLIAMIN, PANVITAN, CYANOCOBALAMIN, DECADRON. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #4588946-5
Alimta side effect was reported by a Health Professional from on Feb 02, 2005. Male patient, 57 years of age, weighting 242.5 lb, was diagnosed with peritoneal mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: cardiomegaly, cholelithiasis, disease progression, dyspnoea exacerbated, hepatic failure, metastases to liver, nephropathy, night sweats, pancreatic necrosis. Alimta dosage: 500 MG/M2. During the same period patient was treated with CISPLATIN, VITAMIN B, DEXAMETHASONE, LISINOPRIL, LEVAQUIN, ARANESP. Patient was hospitalized. Patient died on 01/24/2005.


Alimta Side Effects Report #4870122-X
Alimta side effect was reported by a Pharmacist from UNITED STATES on Dec 29, 2005. Male patient, weighting 180.0 lb, was diagnosed with peritoneal mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: arthralgia, disease progression, joint effusion, musculoskeletal stiffness, neuropathy, swelling. Alimta dosage: 980 MG Q 3 WEEK. During the same period patient was treated with CISPLATIN, CARBOPLATIN. Patient recovered.

Alimta Side Effects Report #4666567-3
Alimta side effect was reported by a Health Professional from on Apr 28, 2005. Female patient, 84 years of age, was diagnosed with non-small cell lung cancer stage iv and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, disease progression, thrombocythaemia, thrombocytopenia. Alimta dosage: 1000 MG OTHER. During the same period patient was treated with GEMZAR, FOLIC ACID, VITAMIN B, DECADRON, ARANESP, LEVOXYL. Patient recovered.

Alimta Side Effects Report #4662283-2
Alimta side effect was reported by a Pharmacist from on Apr 22, 2005. Male patient, 73 years of age, weighting 180.8 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Alimta. After drug was administered, patient experienced the following side effects: anorexia, blister, dehydration, disease progression, erythema, gastroenteritis , nausea , non-small cell lung cancer, oedema peripheral. Alimta dosage: 990 MG OTHER. During the same period patient was treated with FOLIC ACID, VITAMIN B, DEXAMETHASONE, PRILOSEC, PROCHLORPERAZINE, SALSALATE. Patient recovered.

Alimta Side Effects Report #4735202-8
Alimta side effect was reported by a Health Professional from UNITED STATES on July 20, 2005. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer stage iii and was treated with Alimta. After drug was administered, patient experienced the following side effects: abdominal adhesions, abdominal pain lower, anorexia, aspartate aminotransferase increased, asthenia, blood urea increased, diarrhoea, disease progression, gallbladder enlargement. Alimta dosage: 500 MG/M2. During the same period patient was treated with VITAMIN B, FOLIC ACID, DEXAMETHASONE, NITROGLYCERIN, LIPITOR, LOPRESSOR, NIFEDICAL, DIOVAN. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #4724031-7
Alimta side effect was reported by a Physician from UNITED KINGDOM on July 01, 2005. Male patient, 72 years of age, weighting 167.6 lb, was diagnosed with non-small cell lung cancer recurrent and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood potassium decreased, confusional state, decreased appetite, disease progression, fatigue, haemoglobin decreased, immunosuppression. Alimta dosage: 1700 MG/1 OTHER. During the same period patient was treated with FOLIC ACID, VITAMIN B, ISOSORIDE MONONITRATE, ATORVASTATIN CALCIUM, DOCUSATE, METOCLOPRAMIDE, FLUCONAZOLE, SENNA. Patient was hospitalized. Patient recovered.


Alimta Side Effects Report #4713665-1
Alimta side effect was reported by a Health Professional from UNITED STATES on June 27, 2005. Male patient, 59 years of age, weighting 180.8 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, band neutrophil percentage increased, condition aggravated, disease progression, epistaxis, hypovolaemia, lymphocyte percentage increased, monocyte percentage increased, neutropenia. Alimta dosage: 500MG/M2. During the same period patient was treated with VITAMIN B, FOLIC ACID, DECADRON, OXYCONTIN, XANAX, AMBIEN, LANTUS, OXYCODONE. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #4614577-4
Alimta side effect was reported by a Physician from on Nov 09, 2004. Female patient was diagnosed with non-small cell lung cancer metastatic and was treated with Alimta. After drug was administered, patient experienced the following side effects: disease progression, fatigue, nausea . Alimta dosage: 500 MG/M2. During the same period patient was treated with FOLIC ACID, VITAMIN B. Patient recovered.

Alimta Side Effects Report #4614600-7
Alimta side effect was reported by a Health Professional from on Nov 09, 2004. Female patient, 78 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: disease progression, rash . Alimta dosage: 500 MG/M2. During the same period patient was treated with VITAMIN B, FOLIC ACID, DEXAMETHASONE. Patient recovered.

Alimta Side Effects Report #4710652-4
Alimta side effect was reported by a Physician from UNITED KINGDOM on June 22, 2005. Male patient, 72 years of age, weighting 167.6 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood urea increased, confusional state, cough, decreased appetite, disease progression, fatigue, haemoglobin abnormal. Alimta dosage: 1700 MG/1 OTHER. During the same period patient was treated with FOLIC ACID, VITAMIN B, ISOSORBIDE MONONITRATE, ATORVASTATIN CALCIUM, DOCUSATE, METOCLOPRAMIDE, FLUCONAZOLE, SENNA. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #5749849-3
Alimta side effect was reported by a Physician from GERMANY on May 20, 2008. Male patient, 66 years of age, weighting 132.3 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: disease progression, febrile neutropenia, sepsis . Alimta dosage: 500 MG/M2, UNK. During the same period patient was treated with FOLIC ACID, DEXAMETHASONE, VITAMIN B, ANTIEMETICS AND ANTINAUSEANTS. Patient died on 01/01/2008.


Alimta Side Effects Report #5270278-3
Alimta side effect was reported by a Physician from AUSTRALIA on Mar 12, 2007. Female patient, 62 years of age, weighting 130.1 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: blepharitis, conjunctivitis, diarrhoea, disease progression, rash maculo-papular. Alimta dosage: 800 MG, UNK. During the same period patient was treated with FOLIC ACID, VITAMIN B CAP, DEXAMETHASONE. Patient was hospitalized. Patient died on 03/02/2007.

Alimta Side Effects Report #5282903-1
Alimta side effect was reported by a Physician from AUSTRALIA on Mar 23, 2007. Female patient, 62 years of age, weighting 130.1 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: blepharitis, conjunctivitis, diarrhoea, disease progression, rash maculo-papular. Alimta dosage: 800 MG, UNK. During the same period patient was treated with FOLIC ACID, VITAMIN B CAP, DEXAMETHASONE, LITHIUM CARBONATE, VENLAFAXINE, VALACYCLOVIR. Patient was hospitalized. Patient died on 03/02/2007.

Alimta Side Effects Report #6099908-3
Alimta side effect was reported by a Physician from BRAZIL on Feb 09, 2009. Female patient, 56 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: chest pain , disease progression. Alimta dosage: unknown. During the same period patient was treated with FOLIC ACID. Patient was hospitalized. Patient died on 01/26/2009.

Alimta Side Effects Report #4875945-9
Alimta side effect was reported by a Physician from UNITED STATES on Oct 19, 2005. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: cellulitis , disease progression. Alimta dosage: unknown. During the same period patient was treated with VITAMIN B. Patient recovered.

Alimta Side Effects Report #4797319-1
Alimta side effect was reported by a Physician from UNITED STATES on May 16, 2005. Male patient, 45 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: anorexia, asthenia, constipation , cough, dehydration, disease progression, fatigue. Alimta dosage: 500 MG/M2. During the same period patient was treated with GEMZAR, FOLIC ACID, VITAMIN B, DEXAMETHASONE, CISPLATIN, TAXOL, TARCEVA. Patient was hospitalized. Patient recovered.


Alimta Side Effects Report #5503138-0
Alimta side effect was reported by a Physician from SWITZERLAND on Oct 24, 2007. Female patient, weighting 103.6 lb, was diagnosed with non-small cell lung cancer, prophylaxis, prophylaxis of nausea and vomiting and was treated with Alimta. After drug was administered, patient experienced the following side effects: disease progression, somnolence. Alimta dosage: 750 MG, UNK. During the same period patient was treated with FOLIC ACID, FORTECORTIN, VITAMIN B, NAVOBAN. Patient died on 09/15/2007.

Alimta Side Effects Report #5507825-X
Alimta side effect was reported by a Physician from SWITZERLAND on Oct 26, 2007. Female patient, weighting 103.6 lb, was diagnosed with non-small cell lung cancer, prophylaxis, prophylaxis of nausea and vomiting and was treated with Alimta. After drug was administered, patient experienced the following side effects: disease progression, somnolence. Alimta dosage: 750 MG, UNK. During the same period patient was treated with FOLIC ACID, FORTECORTIN, VITAMIN B, NAVOBAN. Patient died on 09/15/2007.

Alimta Side Effects Report #5531898-1
Alimta side effect was reported by a Physician from SWITZERLAND on Nov 22, 2007. Female patient, weighting 103.6 lb, was diagnosed with non-small cell lung cancer, prophylaxis, prophylaxis of nausea and vomiting and was treated with Alimta. After drug was administered, patient experienced the following side effects: disease progression, somnolence. Alimta dosage: 750 MG, UNK. During the same period patient was treated with FOLIC ACID, FORTECORTIN, VITAMIN B, NAVOBAN. Patient died on 09/15/2007.

Alimta Side Effects Report #5887504-X
Alimta side effect was reported by a Health Professional from UNITED STATES on Sept 17, 2008. Male patient, weighting 185.0 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, disease progression, neutropenia, thrombocytopenia. Alimta dosage: 900 MG EVERY 3 WEEKS IV. Patient was hospitalized. Patient died on 09/08/2008.

Alimta Side Effects Report #6128274-X
Alimta side effect was reported by a Physician from UNITED STATES on Mar 16, 2009. Male patient, weighting 197.0 lb, was diagnosed with non-small cell lung cancer, cardiovascular disorder, diarrhoea, nausea  and was treated with Alimta. After drug was administered, patient experienced the following side effects: constipation , dehydration, disease progression, hypotension, tachycardia. Alimta dosage: unknown. During the same period patient was treated with AVASTIN, ENZASTAURIN, ERLOTINIB, CARDURA, ASPIRIN, IMODIUM, PHENERGAN. Patient was hospitalized. Patient recovered.


Alimta Side Effects Report #5006312-5
Alimta side effect was reported by a Health Professional from UNITED STATES on May 17, 2006. Male patient was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: asthenia, disease progression, mental status changes, mood altered. Alimta dosage: 500 MG/M2 Q21 D IV. During the same period patient was treated with BORTIZOMIB. Patient died on 05/05/2006.

Alimta Side Effects Report #5531838-5
Alimta side effect was reported by a Health Professional from UNITED STATES on Nov 27, 2007. Female patient, weighting 126.0 lb, was diagnosed with metastatic neoplasm and was treated with Alimta. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , constipation , disease progression, flatulence, urinary tract infection . Alimta dosage: 500 MG/M2 D 1,8 Q 21 D IV. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #5523240-7
Alimta side effect was reported by a Health Professional from UNITED STATES on Nov 16, 2007. Female patient, weighting 135.0 lb, was diagnosed with metastasis, neoplasm malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: disease progression, haemoglobin decreased, pulmonary embolism , vaginal haemorrhage. Alimta dosage: 500 MG/M2 D 1, 8 Q 21 D IV. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #4970079-7
Alimta side effect was reported by a Physician from UNITED STATES on Mar 22, 2006. Male patient, 64 years of age, was diagnosed with mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, disease progression, haemorrhoidal haemorrhage, neutropenia, pain , renal failure acute, respiratory failure. Alimta dosage: unknown. During the same period patient was treated with CISPLATIN, PRILOSEC, INDOCIN, VITAMINS, NEURONTIN, METFORMIN, GLIPIZIDE, LISINOPRIL. Patient was hospitalized. Patient died.

Alimta Side Effects Report #4987610-8
Alimta side effect was reported by a Physician from UNITED STATES on Apr 07, 2006. Male patient, 64 years of age, was diagnosed with mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, disease progression, haemorrhoidal haemorrhage, neutropenia, pitting oedema, renal failure acute, respiratory failure. Alimta dosage: unknown. During the same period patient was treated with CISPLATIN, PRILOSEC, INDOCIN, NEURONTIN, METFORMIN, GLIPIZIDE, LISINOPRIL, PERCOCET. Patient was hospitalized. Patient died on 03/05/2006.


Alimta Side Effects Report #5025529-7
Alimta side effect was reported by a Consumer or non-health professional from FRANCE on May 30, 2006. Male patient, 62 years of age, was diagnosed with mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: disease progression, pulmonary embolism . Alimta dosage: 876 MG, OTHER, INTRAVENOUS. During the same period patient was treated with GEMZA, SPECIAFOLDINE, AMITRIPTYLINE, MORPHINE SULPHATE. Patient was hospitalized. Patient died on 09/05/2005.

Alimta Side Effects Report #4806804-5
Alimta side effect was reported by a Physician from HUNGARY on Oct 03, 2005. Male patient, 63 years of age, weighting 136.7 lb, was diagnosed with mesothelioma  and was treated with Alimta. After drug was administered, patient experienced the following side effects: acute abdomen, arteriosclerosis, colitis, disease progression, pelvic neoplasm, peritoneal carcinoma, peritonitis. Alimta dosage: 850 MG/1 OTHER. During the same period patient was treated with FOLIC ACID, MEDROL, VITAMIN B. Patient was hospitalized. Patient died on 06/28/2005.

Alimta Side Effects Report #4742576-0
Alimta side effect was reported by a Physician from UNITED STATES on July 26, 2005. Male patient, 62 years of age, weighting 196.2 lb, was diagnosed with mesothelioma  and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood sodium decreased, disease progression, dyspnoea, haematocrit decreased, haemoglobin decreased, ototoxicity, pleural effusion. Alimta dosage: 400 MG WEEK. During the same period patient was treated with GEMZAR, CISPLATIN, VITAMIN B, FOLIC ACID, PRILOSEC, VICODIN, TESSALON, FUROSEMIDE. Patient was hospitalized. Patient died on 05/23/2005.

Alimta Side Effects Report #4680411-X
Alimta side effect was reported by a Physician from on May 18, 2005. Male patient, 59 years of age, was diagnosed with mesothelioma  and was treated with Alimta. After drug was administered, patient experienced the following side effects: anorexia, asthenia, diarrhoea, disease progression, leukopenia, melaena, refusal of treatment by patient. Alimta dosage: 1000 MG/1 OTHER. During the same period patient was treated with CARBOPLATIN, OMEPRAZOLE, FOLIC ACID, VITAMIN B, DEXAMETHASONE. Patient died on 05/12/2005.

Alimta Side Effects Report #5339544-7
Alimta side effect was reported by a Physician from UNITED STATES on Jan 25, 2007. Male patient, 47 years of age, was diagnosed with mesothelioma  and was treated with Alimta. After drug was administered, patient experienced the following side effects: disease progression. Alimta dosage: unknown. During the same period patient was treated with CISPLATIN, FOLIC ACID, VITAMIN B. Patient recovered.


Alimta Side Effects Report #4611094-2
Alimta side effect was reported by a Physician from on Oct 05, 2004. Male patient, 42 years of age, was diagnosed with mesothelioma  and was treated with Alimta. After drug was administered, patient experienced the following side effects: asthma , disease progression, dyspnoea, post procedural vomiting, pyrexia, rash , tachypnoea. Alimta dosage: 500 MG/M2 OTHER. During the same period patient was treated with GEMZAR, CISPLATIN, VITAMIN B, FOLIC ACID, DECADRON SRC, EXTRA STRENGTH TYLENOL, COLACE, SPIRIVA. Patient was hospitalized. Patient recovered.